-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Reiterates Buy on Radiopharm Theranostics, Raises Price Target to $16

Benzinga·12/16/2025 15:10:49
語音播報
B. Riley Securities analyst Yuan Zhi reiterates Radiopharm Theranostics (NASDAQ:RADX) with a Buy and raises the price target from $13 to $16.